Enovix: Executing On Commercialization And Manufacturing Milestones

Daniel Grizelj Enovix (NASDAQ:ENVX) continued to show strong commercial traction, which validates both its technology and premium pricing. With first samples going out to customers, this process of obtaining purchase orders has started, and I will be watching for key commercial milestones like the start of production of the Fab-2 high-volume manufacturing line and winning of any purchase orders with large customers. I have written extensively about Enovix, which can be found here. I think Enovix is starting ...